Skip to content

Clinical trials

Phase 1/2 Multiple Myeloma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 1/2 Country / region: United States Clear all

288 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20015
20026
20037
20048
200510
20069
200714
200810
200910
201019
201117
201217
201314
201411
201510
201612
20177
201812
201919
20206
20219
202212
202310
20244
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed137
Terminated70
Recruiting29
Active, not recruiting23
Unknown status14
Withdrawn9
Suspended5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic16
Fred Hutchinson Cancer Center11
M.D. Anderson Cancer Center11
National Cancer Institute (NCI)11
Celgene8
GlaxoSmithKline8
Hackensack Meridian Health7
H. Lee Moffitt Cancer Center and Research Institute6
Incyte Corporation6
Memorial Sloan Kettering Cancer Center6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma288
Neoplasms, Plasma Cell48
Recurrence40
Lymphoma, Non-Hodgkin34
Hodgkin Disease33
Lymphoma32
Leukemia31
Myelodysplastic Syndromes27
Leukemia, Myeloid, Acute26
Leukemia, Lymphocytic, Chronic, B-Cell25

Trials

Showing 1 to 25 of 288. Each trial links to its page on Pharma Observatory.

188 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.